Smoked cocaine self-administration in females and voucher incentives for abstinence

Journal of Substance Abuse

Volumn 10, Issue 2, 1998, Pages 143-162

  Evans, Suzette M ^a   Levin, Frances R ^b   Fischman, Marian W ^b   Foltin, Richard W ^b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE;

ABSTINENCE; ADULT; ARTICLE; BLOOD PRESSURE; COCAINE DEPENDENCE; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; HUMAN EXPERIMENT; OUTPATIENT; PRIORITY JOURNAL; TREATMENT INDICATION; URINALYSIS; WITHDRAWAL SYNDROME;

EID: 0032228888     PISSN: 08993289     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-3289(99)80130-8     Document Type: Article

References (53)

1. Ambre JJ, Belknap SM, Nelson J, Ruo TI, Shin S, Atkinson AJ: Acute tolerance to cocaine in humans. Clin Pharmacol Ther 44: 1-8, 1988.
2. Baumann MH, Gendron TM, Becketts KM, Henningfield JE, Gorelick DA, Rothman RB: Effects of intravenous cocaine on plasma cortisol and prolactin in human cocaine abusers. Bio Psych 38: 751-755, 1995.
3. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psych 4: 561-571, 1961.
4. Brower KJ, Maddahian E, Blow FC, Beresford TP: A comparison of self-reported symptoms and DSM-III-R criteria for cocaine withdrawal. Am J Drug Alcohol Abuse 14: 347-356, 1988.
5. Dudish SA, Pentel PR, Hatsukami, DK: Smoked cocaine self administration in females. Psychopharm 123: 79-87, 1996.
6. Elk R, Schmitz J, Spiga R, Rhoades H, Andres R, Grabowski J: Behavioral treatment of cocaine-dependent pregnant women and TB-exposed patients. Addict Behav 20: 533-542, 1995.
7. Ellis BW, Johns MW, Lancaster R, Raptopoulos P, Angelopoulos N, Priest RG: The St. Mary's hospital sleep questionnaire. Sleep 4: 93-97, 1981.
8. Endicott J, Nee J, Cohen J, Halbreich U: Premenstrual changes: patterns and correlates of daily ratings. J Affect Disord 10: 127-135, 1986.
9. Evans SM, Cone EJ, Henningfield JE: Arterial and venous cocaine plasma concentrations in humans: Relationship to route of administration, cardiovascular effects and subjective effects. J Pharmacol Exp Ther 279: 1345-1356, 1996.
10. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured clinical interview for DSM-IV Axis I disorders- Patient Edition (SCID-I/P, version 2.0). Biometrics Research Department, New York State Psychiatric Institute, 1995.
11. Fischman MW, Schuster CR, Javaid J, Hatano Y, Davis J: Acute tolerance development to the cardiovascular and subjective effects of cocaine. J Pharmacol Exp Ther 235: 677-682, 1985.
12. Fischman MW, Schuster CR, Resnekov L, Snick JFE, Krasnegor NA, Fennell W, Freedman DX: Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch Gen Psych 33: 983-989, 1976.
13. Foltin RW, Fischman MW: Smoked and intravenous cocaine in humans: Acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther 257: 247-261, 1991.
14. Foltin RW, Fischman MW: Residual effects of repeated cocaine smoking in humans. Drug Alcohol Depend 47: 117-124, 1997a.
15. Foltin RW, Fischman MW: A laboratory model of cocaine withdrawal in humans: Intravenous cocaine. Exp Clin Psychopharmacol 5: 404-411, 1997b.
16. Foltin RW, Fischman MW, Nestadt G, Stromberger H, Cornell EE, Pearlson GD: Demonstration of naturalistic methods for cocaine smoking by human volunteers. Drug Alcohol Depend 26: 145-154, 1990.
17. Gawin FH, Kleber HD: Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Arch Gen Psych 43: 107-113, 1986.
18. Giannini AJ, Foils DJ, Feather JN, Sullivan BS: Bromocriptine and amantadine in cocaine detoxification. Psych Res 29: 11-16, 1989.
19. Gill K, Gillespie HK, Hollisler LE, Davis CM, Peabody CA: Dopamine depletion hypothesis of cocaine dependence: A test. Human Psychopharmacol 6: 25-29, 1991.
20. Griffin ML, Weiss RD, Mirin SM, Lange U: A comparison of male and female cocaine abusers. Arch Gen Psych 46: 122-126, 1989.
21. Hamilton M: The assessment of anxiety states by rating. Br J Med Psych 32: 50-55, 1959.
22. Hamilton M: A rating scale for depression. JNeur Neurosurg Psych 23: 56-62, 1960.
23. Haney M, Foltin RW, Fischman MW: Effects of pergolide on intravenous cocaine self-administration in men and women. Psychopharmacol 137: 15-24, 1998.
24. Hatsukami D, Keenan R, Carroll M, Colon E, Geiske D, Wilson B, Huber M: A method for delivery of precise doses of smoked cocaine-base to humans. Pharmacol Biochem Behav 36: 1-7, 1990.
25. Hatsukami DK, Pentel PR, Glass J, Nelson R, Brauer LH, Crosby R, Hanson K: Methodological issues in the administration of multiple doses of smoked cocaine-base in humans. Pharmacol Biochem Behav 47: 531-540, 1994.
26. Higgins ST, Budney AJ, Bickel WK: Applying behavioral concepts and principles to the treatment of cocaine dependence. Drug Alcohol Depend 34: 87-97, 1994.
27. Higgins ST, Budney AJ, Bickel WK, Hughes JR, Foerg F, Badger G: Achieving cocaine abstinence with a behavioral approach. Am J Psych 150: 763-769, 1993.
28. Higgins ST, Delaney DD, Budney AJ, Bickel WK, Hughes JR, Foerg F, Fenwick JW: A behavioral approach to achieving initial cocaine abstinence. Am J Psych 148: 1218-1224, 1991.
29. Isenschmid DS, Fischman MW, Foltin RW, Caplan YH: Concentration of cocaine and metabolites in plasma of human volunteers following intravenous and smoked administration of cocaine. J Anal Toxicol 16: 311-314, 1992.
30. Johanson CE, Fischman MW: The pharmacology of cocaine related to its abuse. Pharm Rev 41: 3-52, 1989.
31. Kosten TR, Kosten TA, McDougle CJ, Hameedi FA, McCance EF, Rosen MI, Oliveto AH, Price LH: Gender differences in response to intranasal cocaine administration to humans. Bio Psych 39: 147-148, 1996.
32. Kranzler HR, Dale WJ: Serum prolactin level, craving, and early discharge from treatment in cocaine dependent patients. Am J Drug Alcohol Abuse 18: 187-195, 1992.
33. Kumor KM, Sherer MA, Gomez J, Cone E, Jaffe JH: Subjective response during continuous infusion of cocaine. Pharmacol Biochem Behav 33: 443-452, 1989.
34. Lukas SE, Sholar M, Hundahl LH, Lamas X, Kouri E, Wines JD, Kragie L, Mendelson JH: Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacol 125: 346-354, 1996.
35. Martin SD, Yeragani VK, Lodhi R, Galloway MP: Clinical ratings and plasma HVA during cocaine abstinence. Biol Psych 26: 356-362, 1989.
36. Mello NK, Mendelson JH: Cocaine's effects on neuroendocrine systems: clinical and preclinical studies. Pharmacol Biochem Behav 57: 571-599, 1997.
37. Mendelson JH, Teoh SK, Lange U, Mello NK, Weiss R, Skupny A, Ellingboe J: Anterior pituitary, adrenal, and gonadal hormones during cocaine withdrawal. Am J Psych 145: 1094-1098, 1988.
38. Mendelson JH, Teoh SK, Mello NK, Ellingboe J, Rhoades E: Acute effects of cocaine on plasma adrenocorticotropic hormone, luteinizing hormone and prolactin levels in cocaine-dependent men. J Pharmacol Exp Ther 263: 505-509, 1992.
39. Preston KL, Silverman K, Schuster CR, Cone EJ: Assessment of cocaine use with quantitative uri-nalysis and estimation of new uses. Addiction 92: 717-727, 1997.
40. Resnick RB, Schuyten-Resnick E: Clinical aspects of cocaine: Assessment of cocaine abuse behavior in man. In Cocaine: Chemical, Biological, Clinical, Social and Treatment Aspects, edited by Mule, SJ. Cleveland, OH, CRC Press, 219-228, 1976.
41. Satel SL, Price LH, Palumbo JM, McDougle CJ, Krystal JH, Gawin F, Charney DS, Heninger GR, Kleber HD: Clinical phenomenology and neurobiology of cocaine abstinence: A prospective inpatient study. Am J Psych 148: 1712-1716, 1991.
42. Siegel RK: Cocaine smoking. J Psychoactive Drugs 14: 271-359, 1982.
43. Silverman K, Higgins ST, Brooner RK, Montoya ID, Cone EJ, Schuster CR, Preston KL: Sustained cocaine abstinence, in methadone maintenance patients through voucher-based reinforcement therapy. Arch Gen Psych 53: 409-415, 1996a.
44. Silverman K, Wong CJ, Higgins ST, Brooner RK, Montoya ID, Contoreggi C, Umbricht-Schneiter A, Schuster CR, Preston KL: Increasing opiate abstinence through voucher-based reinforcement therapy. Drug Alcohol Depend 41: 157-165, 1996b.
45. Smith DE: Diagnostic, treatment and aftercare approaches to cocaine abuse. J Subst Abuse Treat 1: 5-9, 1984.
46. Spielberger CD, Gorsuch RL, Lushene RE: STAI Manual for the State-Trait Anxiety Inventory ("Self-Evaluation Questionnaire). Palo Alto, CA, Consulting Psychologists Press, 1970.
47. Svikis DS, Lee JH, Haug NA, Stitzer ML: Attendance incentives for outpatient treatment: effects in methadone- and nonmethadone-maintained pregnant drug dependent women. Drug Alcohol Depend 48: 33-41, 1997.
48. Tunis SL, Delucchi K, Hall SH: Assessing thoughts about cocaine and their relationship to short-term treatment outcome. Exp Clin Psychopharmacol 2: 184-193, 1994.
49. Trinkoff AM, Ritter C, Anthony JC: The prevalence and self-reported consequences of cocaine use: An exploratory and descriptive analysis. Drug Alcohol Depend 26: 217-225, 1990.
50. U.S. Department of Health and Human Services: Preliminary Estimates from the 1993 National Household Survey on Drug Abuse. Substance Abuse and Mental Health Services Administration, Washington, DC, 1993.
51. Ward AS, Haney M, Fischman MW, Foltin RW: Binge cocaine self-administration in humans: Intravenous cocaine. Psychopharm 132: 375-381, 1997a.
52. Ward, AS, Haney M, Fischman MW, Foltin RW: Binge cocaine self-administration in humans: Smoked cocaine. Behav Psychopharmacol 8: 736-744, 1997b.
53. Weddington WW, Brown BS, Haertzen CA, Cone FJ, Dax EM, Herning RI, Michaelson BS: Changes in mood, craving, and sleep during short term abstinence reported by male cocaine addicts. Arch Gen Psych 47: 861-868, 1990.